Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Follitropin delta individualized dosing in long GnRH agonist versus GnRH antagonist protocols for controlled ovarian stimulation
2017-002783-40Phase 3Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Nov 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of follitropin delta in female infertility (2 arms), sponsored by Ferring Pharmaceuticals. Primary endpoint: Number of oocytes retrieved. Started Nov 2018; status: completed.
02
Drugs
follitropin delta
03
Conditions
female infertility
Beyond the preview
Go deeper on 2017-002783-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002783-40.